does kaiser offer semaglutide Recently approved KP Research Bank studies Kaiser approved me! Yay! :

In Studies 2 (NCT#03548935), 3 (NCT#03552757), and 4 (NCT#03611582), WEGOVY or matching placebo was escalated to 2.4 mg subcutaneous injection weekly during a 16-week period followed by 52 weeks on maintenance dose

4 The available approved agonists include tirzepatide, exenatide, liraglutide, dulaglutide, lixisenatide, and semaglutide

December 18, 2024: FDA Updates Ozempic Warning Label to Include Pulmonary Aspiration as Adverse Reaction The FDA updated the warning label for Ozempic, the GLP-1 drug used to treat diabetes and lose weight

One study in rats showed that ginseng compounds improved blood sugar and cholesterol levels while boosting GLP-1 release after 4 weeks of supplementation

This does not predict future response